Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 345

1.

Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI.

Mol Psychiatry. 2019 Jan 7. doi: 10.1038/s41380-018-0311-2. [Epub ahead of print]

PMID:
30617276
2.

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI.

Mol Psychiatry. 2018 Oct 3. doi: 10.1038/s41380-018-0256-5. [Epub ahead of print] Erratum in: Mol Psychiatry. 2019 Jan 7;:.

PMID:
30283029
3.

Diagnostic differences in verbal learning strategies and verbal memory in patients with mood disorders and psychotic disorders.

Gill SK, Gomez RG, Keller J, Schatzberg AF.

Psychiatry Res. 2018 Nov;269:733-739. doi: 10.1016/j.psychres.2018.09.003. Epub 2018 Sep 5.

PMID:
30273898
4.

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, Hawkins J, Birnbaum J, Lyons DM, Rodriguez CI, Schatzberg AF.

Am J Psychiatry. 2018 Aug 29:appiajp201818020138. doi: 10.1176/appi.ajp.2018.18020138. [Epub ahead of print]

PMID:
30153752
5.

Cognitive effects of mifepristone in overweight, euthymic adults with depressive disorders.

Roat-Shumway S, Wroolie TE, Watson K, Schatzberg AF, Rasgon NL.

J Affect Disord. 2018 Oct 15;239:242-246. doi: 10.1016/j.jad.2018.07.014. Epub 2018 Jul 10.

PMID:
30025313
6.

Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis.

Hagenauer MH, Schulmann A, Li JZ, Vawter MP, Walsh DM, Thompson RC, Turner CA, Bunney WE, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H.

PLoS One. 2018 Jul 17;13(7):e0200003. doi: 10.1371/journal.pone.0200003. eCollection 2018.

7.

Learning to actively cope with stress in female mice.

Lyons DM, Buckmaster CL, Schatzberg AF.

Psychoneuroendocrinology. 2018 Oct;96:78-83. doi: 10.1016/j.psyneuen.2018.06.010. Epub 2018 Jun 9.

PMID:
29909293
8.

Connective Tissue Growth Factor Is a Novel Prodepressant.

Turner CA, Sharma V, Hagenauer MH, Chaudhury S, O'Connor AM, Hebda-Bauer EK, Thompson RC, Myers RM, Bunney WE, Barchas JD, Lee FS, Schatzberg AF, Watson SJ Jr, Akil H.

Biol Psychiatry. 2018 Oct 15;84(8):555-562. doi: 10.1016/j.biopsych.2018.04.013. Epub 2018 May 3.

9.

Neural cell adhesion molecule peptide mimetics modulate emotionality: pharmacokinetic and behavioral studies in rats and non-human primates.

Turner CA, Lyons DM, Buckmaster CL, Aurbach EL, Watson SJ, Schatzberg AF, Akil H.

Neuropsychopharmacology. 2019 Jan;44(2):356-363. doi: 10.1038/s41386-018-0052-6. Epub 2018 Apr 9.

PMID:
29703997
10.

Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.

Rollins BL, Morgan L, Hjelm BE, Sequeira A, Schatzberg AF, Barchas JD, Lee FS, Myers RM, Watson SJ, Akil H, Potkin SG, Bunney WE, Vawter MP.

Mol Neuropsychiatry. 2018 Feb;3(3):157-169. doi: 10.1159/000484348. Epub 2017 Nov 30.

11.

High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression.

Williams NR, Sudheimer KD, Bentzley BS, Pannu J, Stimpson KH, Duvio D, Cherian K, Hawkins J, Scherrer KH, Vyssoki B, DeSouza D, Raj KS, Keller J, Schatzberg AF.

Brain. 2018 Feb 5. doi: 10.1093/brain/awx379. [Epub ahead of print] No abstract available.

PMID:
29415152
12.

The Black Book of Psychotropic Dosing and Monitoring.

Schatzberg AF, Charles D.

Psychopharmacol Bull. 2018 Jan 15;48(1):64-153. No abstract available.

PMID:
29382960
13.

Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression.

Davis EG, Keller J, Hallmayer J, Pankow HR, Murphy GM Jr, Gotlib IH, Schatzberg AF.

Transl Psychiatry. 2018 Jan 10;8(1):5. doi: 10.1038/s41398-017-0051-0. Review.

14.

Quantitative validation of immunofluorescence and lectin staining using reduced CLARITY acrylamide formulations.

Krolewski DM, Kumar V, Martin B, Tomer R, Deisseroth K, Myers RM, Schatzberg AF, Lee FS, Barchas JD, Bunney WE, Akil H, Watson SJ Jr.

Brain Struct Funct. 2018 Mar;223(2):987-999. doi: 10.1007/s00429-017-1583-z. Epub 2017 Dec 14.

PMID:
29243106
15.

Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.

O'Connell CP, Goldstein-Piekarski AN, Nemeroff CB, Schatzberg AF, Debattista C, Carrillo-Roa T, Binder EB, Dunlop BW, Craighead WE, Mayberg HS, Williams LM.

Am J Psychiatry. 2018 Mar 1;175(3):251-261. doi: 10.1176/appi.ajp.2017.17020172. Epub 2017 Dec 15.

PMID:
29241359
16.

Stress amplifies sex differences in primate prefrontal profiles of gene expression.

Lee AG, Hagenauer M, Absher D, Morrison KE, Bale TL, Myers RM, Watson SJ, Akil H, Schatzberg AF, Lyons DM.

Biol Sex Differ. 2017 Nov 2;8(1):36. doi: 10.1186/s13293-017-0157-3.

17.

Post-mortem molecular profiling of three psychiatric disorders.

Ramaker RC, Bowling KM, Lasseigne BN, Hagenauer MH, Hardigan AA, Davis NS, Gertz J, Cartagena PM, Walsh DM, Vawter MP, Jones EG, Schatzberg AF, Barchas JD, Watson SJ, Bunney BG, Akil H, Bunney WE, Li JZ, Cooper SJ, Myers RM.

Genome Med. 2017 Jul 28;9(1):72. doi: 10.1186/s13073-017-0458-5.

18.

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.

Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB; American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments.

JAMA Psychiatry. 2017 Apr 1;74(4):399-405. doi: 10.1001/jamapsychiatry.2017.0080. Review.

PMID:
28249076
19.

Erratum: Resting-state connectivity biomarkers define neurophysiological subtypes of depression.

Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C.

Nat Med. 2017 Feb 7;23(2):264. doi: 10.1038/nm0217-264d. No abstract available.

20.

Side Effects to Antidepressant Treatment in Patients With Depression and Comorbid Panic Disorder.

Shankman SA, Gorka SM, Katz AC, Klein DN, Markowitz JC, Arnow BA, Manber R, Rothbaum BO, Thase ME, Schatzberg AF, Keller MB, Trivedi MH, Kocsis JH.

J Clin Psychiatry. 2017 Apr;78(4):433-440. doi: 10.4088/JCP.15m10370.

PMID:
28068460

Supplemental Content

Loading ...
Support Center